RVMD
$101.58
Net Profits | $-364.89Mn |
Revolution Medicines Inc’s net profit fell -87.54% since last year same period to $-364.89Mn in the Q4 2025. On a quarterly growth basis, Revolution Medicines Inc has generated -19.56% fall in its net profits since last 3-months.
EPS Estimate Current Quarter | -1.64 |
EPS Estimate Current Year | -1.64 |
Revolution Medicines Inc’s earning per share (EPS) estimates for the current quarter stand at -1.64 - a -3.8% fall from last quarter’s estimates.
Revolution Medicines Inc’s earning per share (EPS) estimates for the current year stand at -1.64.
Earning Per Share (EPS) | 0 |
Revolution Medicines Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Revolution Medicines Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-11 | -1.64 | 0 | 100% |